Ledger.Open graph →
SEC Form D · filed July 7, 2016

EYEGATE PHARMACEUTICALS INC

Offering
$3.8M
Sold
$3.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Morton Goldberg · Waltham, MADirectorThomas Hancock · Waltham, MADirectorPraveen Tyle · Waltham, MADirectorPaul Chaney · Waltham, MADirectorStephen From · Waltham, MAExec · DirectorBernard Malfroy-Camine · Waltham, MADirectorRyan Brenneman · Waltham, MAExecThomas Balland · Waltham, MADirectorMorton Goldberg · Waltham, MADirectorThomas Hancock · Boston, MADirectorPraveen Tyle · Waltham, MADirectorPaul Chaney · Melville, NYDirectorRyan Brenneman · Waltham, MAExecStephen From · Waltham, MAExec · DirectorBernard Malfroy-Camine · Arlington, MADirectorThomas Balland · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗